During the study period, 327 men with prostate cancer were referred to the radiation oncology department of our institution following RT of the prostate or PF, as part of surveillance or for suspicion of relapse; and subsequently underwent 68Ga-PSMA PET/CT surveillance. This evidence concerns the gene FOLH1 and prostate cancer.